Capital Expenditures for Thermo Fisher Scientific (TMO)
According to Thermo Fisher Scientific's latest reported financial statements, the company's current capital expenditures (TTM) is $1.54B USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingCapital ExpendituresSwitch metric
Latest period
$1.54B
YoY change
+8.9%
5Y CAGR
+0.7%
Peak year (2021)
$2.52B
Cumulative capital expenditures
$18.75B
CapEx history chart for Thermo Fisher Scientific (TMO) from 1989 to 2025
CapEx history table for Thermo Fisher Scientific (TMO) from 1989 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $1.52B | +8.9% | ||
| 2024 | $1.40B | -5.3% | ||
| 2023 | $1.48B | -34.1% | ||
| 2022 | $2.24B | -11.1% | ||
| 2021 | $2.52B | +71.2% | ||
| 2020 | $1.47B | +59.2% | ||
| 2019 | $926.00M | +22.2% | ||
| 2018 | $758.00M | +49.2% | ||
| 2017 | $508.00M | +14.3% | ||
| 2016 | $444.40M | +5.1% | ||
| 2015 | $422.90M | -1.1% | ||
| 2014 | $427.60M | +51.4% | ||
| 2013 | $282.40M | -10.4% | ||
| 2012 | $315.10M | +18.2% | ||
| 2011 | $266.50M | +0.4% | ||
| 2010 | $265.50M | +28.0% | ||
| 2009 | $207.50M | -21.5% | ||
| 2008 | $264.40M | +50.7% | ||
| 2007 | $175.50M | +128.5% | ||
| 2006 | $76.80M | +76.4% | ||
| 2005 | $43.55M | -12.9% | ||
| 2004 | $49.98M | +8.3% | ||
| 2003 | $46.14M | -9.9% | ||
| 2002 | $51.21M | -39.6% | ||
| 2001 | $84.80M | +14.5% | ||
| 2000 | $74.04M | -84.8% | ||
| 1999 | $488.00M | +21.6% | ||
| 1998 | $401.20M | -58.2% | ||
| 1997 | $960.70M | +671.6% | ||
| 1996 | $124.50M | +97.9% | ||
| 1995 | $62.90M | +4.5% | ||
| 1994 | $60.20M | +6.4% | ||
| 1993 | $56.60M | -5.7% | ||
| 1992 | $60.00M | +79.1% | ||
| 1991 | $33.50M | -72.1% | ||
| 1990 | $120.00M | +150.5% | ||
| 1989 | $47.90M | — |
CapEx values are taken from Thermo Fisher Scientific's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Thermo Fisher Scientific (TMO) capital expenditures totalled $1.52B – grew 8.9% year-over-year.
Thermo Fisher Scientific capital expenditures has recorded the values shown across consecutive periods, with a +0.7% compound annual growth rate over 2020–2025 (5 years).
Thermo Fisher Scientific capital expenditures plunged from $2.52B in 2021 to $1.52B in 2025, a 39.6% drawdown.
The dataset's maximum capital expenditures sits at $2.52B (2021); the minimum reading of $33.50M dates to 1991.
Thermo Fisher Scientific (TMO) sits 8th of 8 Healthcare peers we track on this metric, against a peer median of $3.87B.
Thermo Fisher Scientific Capital Expenditures by Year
Thermo Fisher Scientific Capital Expenditures 2025: $1.52B
Thermo Fisher Scientific capital expenditures in 2025 was $1.52B, grew 8.9% from 2024.
Thermo Fisher Scientific Capital Expenditures 2024: $1.40B
Thermo Fisher Scientific capital expenditures in 2024 was $1.40B, declined 5.3% below 2023.
Thermo Fisher Scientific Capital Expenditures 2023: $1.48B
Thermo Fisher Scientific capital expenditures in 2023 was $1.48B, plunged 34.1% below 2022.
Thermo Fisher Scientific Capital Expenditures 2022: $2.24B
Thermo Fisher Scientific capital expenditures in 2022 was $2.24B, declined 11.1% below 2021.
Thermo Fisher Scientific Capital Expenditures 2021: $2.52B
Thermo Fisher Scientific capital expenditures in 2021 was $2.52B.
See more financial history for Thermo Fisher Scientific (TMO).
Sector peers — CapEx
Companies in the same sector as Thermo Fisher Scientific, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Thermo Fisher Scientific's capital expenditures?
- Latest reported capital expenditures for Thermo Fisher Scientific (TMO) is $1.54B (period ending March 28, 2026).
How has Thermo Fisher Scientific capital expenditures changed year-over-year?
- Thermo Fisher Scientific (TMO) capital expenditures changed +8.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Thermo Fisher Scientific capital expenditures?
- Thermo Fisher Scientific (TMO) capital expenditures compound annual growth rate is +0.7% over the most recent 5 years available.
When did Thermo Fisher Scientific capital expenditures hit its highest annual value?
- Thermo Fisher Scientific capital expenditures reached its highest annual value of $2.52B in 2021.
What was Thermo Fisher Scientific capital expenditures in 2024?
- Thermo Fisher Scientific (TMO) capital expenditures in 2024 was $1.40B.
What was Thermo Fisher Scientific capital expenditures in 2025?
- Thermo Fisher Scientific (TMO) capital expenditures in 2025 was $1.52B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
TMO Overview
Company profile, financial tools, and key metrics
TMO Revenue Counter
Earns $1,433 every second. See per minute, hour, and day.
TMO Earnings Counter
Earns $217.50 per second net profit. See per minute, hour, and day.
TMO Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
TMO What If Invested
What if you had invested $1,000? See historical returns from any date.
TMO How It Makes Money
Discover visual breakdown of $45.20B in revenue — where it comes from and where it goes.
TMO Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
TMO Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
TMO Daily Price Character
Balanced · 47.1% historical win rate (green days). Streaks & record days.
TMO Buybacks
4.54% TTM buyback yield. Shareholder yield & SBC comparison.
TMO Stock Split History
8 splits on record. Dates, ratios, and cumulative multiple.
TMO Dividend Profile
Yield: 0.38%. Safety: 5/8. See full history.
TMO Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
TMO Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.